Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Exploratory Pharmacodynamic Study of XL765 and XL147 Administered as Single Agents to Subjects With Recurrent Glioblastoma Who Are Candidates for Surgical Resection

NCT01240460 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT01240460
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01240460 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Exploratory Pharmacodynamic Study of XL765 and XL147 Administered as Single Agents to Subjects With Recurrent Glioblastoma Who Are Candidates for Surgical Resection
Lead sponsor
Sanofi
Phase
Phase 1
Overall status
Completed
Start date
January 31, 2011
Completion date
June 30, 2012
Enrollment
40 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

astrocytoma, grade iv, glioblastoma